HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hilary J Longhurst Selected Research

Angioedema

2/2024CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema.
1/2022Treatment of hereditary angioedema-single or multiple pathways to the rescue.
1/2021Managing Chronic Urticaria and Recurrent Angioedema Differently with Advancing Age.
1/2018Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.
1/2017An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension.
6/2016The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks.
9/2014Treatment of hereditary angioedema with icatibant: efficacy in clinical trials versus effectiveness in the real-world setting.
4/2012Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema.
9/2010Management of acute attacks of hereditary angioedema: potential role of icatibant.
9/2004Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hilary J Longhurst Research Topics

Disease

29Hereditary Angioedemas
02/2024 - 04/2007
10Angioedema
02/2024 - 09/2004
4Infections
12/2014 - 01/2004
2Rare Diseases (Rare Disease)
01/2022 - 02/2019
2Hereditary Angioedema Types I and II
01/2019 - 11/2018
2Lymphopenia (Lymphocytopenia)
05/2018 - 01/2017
1Anaphylaxis (Anaphylactic Shock)
01/2022
1Urticaria (Hives)
01/2021
1Dizziness (Lightheadedness)
11/2018
1Injection Site Reaction
11/2018
1Multiple Sclerosis
05/2018
1Body Weight (Weight, Body)
01/2018
1Overweight
01/2018
1IgG Deficiency
01/2017
1Chronic Disease (Chronic Diseases)
06/2016
1Fever (Fevers)
06/2016
1Inflammation (Inflammations)
06/2016
1Pain (Aches)
06/2016
1Hematologic Neoplasms (Hematological Malignancy)
05/2014
1Enteritis
01/2014
1Primary Immunodeficiency Diseases
01/2014
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2014
1Abdominal Pain (Pain, Abdominal)
04/2012
1Polymyositis
01/2011
1Dermatomyositis (Dermatopolymyositis)
01/2011
1Peripheral Nervous System Diseases (PNS Diseases)
01/2011
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2007
1Soft Tissue Infections
09/2004
1Wiskott-Aldrich Syndrome
02/2002

Drug/Important Bio-Agent (IBA)

12icatibantIBA
01/2022 - 09/2010
7BradykininIBA
01/2022 - 09/2010
5Kallikreins (Kallikrein)IBA
02/2024 - 01/2017
5Plasma KallikreinIBA
11/2023 - 01/2017
5Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA
01/2022 - 01/2014
5lanadelumabIBA
01/2021 - 01/2017
3Bradykinin B2 ReceptorIBA
01/2022 - 09/2015
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2021 - 04/2012
2Monoclonal AntibodiesIBA
11/2018 - 01/2017
2Immunoglobulin M (IgM)IBA
01/2017 - 01/2014
2Adrenal Cortex Hormones (Corticosteroids)IBA
05/2014 - 01/2014
2Immunoglobulins (Immunoglobulin)IBA
05/2014 - 01/2014
1CRISPR-Associated Protein 9IBA
02/2024
1sebetralstatIBA
11/2023
1Antisense OligonucleotidesIBA
01/2022
1ecallantideFDA Link
01/2022
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021
1Omalizumab (Xolair)FDA Link
01/2021
1Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA
01/2021
1KininsIBA
02/2019
1CladribineFDA LinkGeneric
05/2018
1Alemtuzumab (Campath)FDA Link
05/2018
1acivicin (AT 125)IBA
01/2018
1berotralstatIBA
01/2018
1EicosanoidsIBA
06/2016
1LipidsIBA
06/2016
1Anti-Bacterial Agents (Antibiotics)IBA
12/2014
1AntibodiesIBA
05/2014
1Anticonvulsants (Antiepileptic Drugs)IBA
05/2014
1Rituximab (Mabthera)FDA Link
01/2014
1conestat alfaIBA
01/2014
1Phospholipases (Phospholipase)IBA
01/2014
1Immunoglobulin A (IgA)IBA
01/2014
1Immunoglobulin G (IgG)IBA
01/2014
1Estrogens (Estrogen)FDA Link
04/2012
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2011
1Creatine Kinase (Creatine Phosphokinase)IBA
01/2011
1Complement C4 (Complement Component 4)IBA
04/2007
1Hormones (Hormone)IBA
09/2004
1Interferon-gamma (Interferon, gamma)IBA
01/2004
1AutoantibodiesIBA
01/2004

Therapy/Procedure

11Therapeutics
02/2024 - 09/2004
2Drug Therapy (Chemotherapy)
01/2014 - 01/2004
1Self Administration (Administration, Self)
07/2019
1Injections
05/2018
1Oral Administration
01/2018
1Immunomodulation
01/2011
1Debridement
09/2004
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2002